Company intelligence
MicroQuin
Revolutionizing Disease/Injury treatment by controlling the Intracellular Environment (ICE)
Biotechnology
Cambridge, US
3 employees
Founded 2018
6 public signals
About MicroQuin
Disease begins inside the cell. So does the solution. At the core of all disease is intracellular environmental change (ICE). MicroQuin have small molecules that can modulate the ICE to slow, stop or reverse disease/injury.
Verified activity
Signals from MicroQuin
6 published signals
Research & Knowledge
MicroQuin published a recent Oncogene publication describing how TMBIM6/BI-1 regulates pathways leading to paraptotic cell death in cancer cells.
Reported by MicroQuin
Partnerships
MicroQuin received support from the United States Department of War Congressionally Directed Medical Research Programs (CDMRP) for supporting research on ovarian cancer and the Ovarian Cancer Research Program.
Reported by MicroQuin
Research & Knowledge
MicroQuin received support from the United States Department of War CDMRP for research on TMBIM6 structural data in microgravity.
Reported by Scott Robinson, PhD, CQF
Research & Knowledge
MicroQuin derived TMBIM6 structural data in a microgravity environment using NASA, Boeing, and the International Space Station National Laboratory.
Reported by Scott Robinson, PhD, CQF
People
MicroQuin employee Tara Tatu helped work out how to use the OnStage incubator for the EVOS7000.
Reported by Scott Robinson, PhD, CQF
People
MicroQuin employee Daniel Yuan helped pull the video together and his prior work on developing these compounds.
Reported by Scott Robinson, PhD, CQF